NT-proBNP a known marker of heart failure released in the ventricles in response to pressure overload or stretching of myocytes are also used together with troponin concentration, a marker of myocardial injury, in diagnosis of cardiotoxity after anti-cancer treatment [7, 24]. Here, NPPB is linked to cancer.